Literature DB >> 11171116

Interaction of phospholipase D1 with a casein-kinase-2-like serine kinase.

I G Ganley1, S J Walker, M Manifava, D Li, H A Brown, N T Ktistakis.   

Abstract

Phospholipase D (PLD)1 was phosphorylated in vivo and by an associated kinase in vitro following immunoprecipitation. Both phosphorylation events were greatly reduced in a catalytically inactive point mutant in which the serine residue at position 911 was converted into alanine (S911A). The kinase could be enriched from detergent-extracted brain membranes and bind and phosphorylate PLD1 that was immunoprecipitated from COS-7 cells. Using in-gel kinase assays we determined that the size of the kinase is approximately 40 kDa and that PLD1 is more effective than S911A in binding the kinase. Preliminary analysis of the phosphorylation sites on PLD1 suggested that the kinase belongs to the casein kinase 2 (CK2) family. Consistent with this, we found that the kinase could utilize GTP, and could be inhibited by heparin and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). Membrane fractions from Chinese hamster ovary (CHO) cell lines that inducibly express PLD1 contained an endogenous kinase activity that phosphorylated PLD1 using GTP and was inhibited by DRB. Direct evidence that the kinase is CK2 came from observations that immunoprecipitates using PLD1 antibodies contained immunoreactive CK2alpha, and immunoprecipitates using CK2alpha antibodies contained immunoreactive PLD1. Co-expression of PLD1 in COS-7 cells with the two recombinant CK2 subunits, alpha or beta, suggests that the association of PLD1 with the kinase is through the beta subunit. Supporting this, phosphorylation of PLD1 by purified recombinant CK2alpha was enhanced by purified recombinant CK2beta. Assays measuring PLD1 catalytic activity following phosphorylation by CK2 suggest that this phosphorylation event does not influence PLD1-mediated hydrolysis of phosphatidylcholine in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171116      PMCID: PMC1221665          DOI: 10.1042/0264-6021:3540369

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Association of the N- and C-terminal domains of phospholipase D. Contribution of the conserved HKD motifs to the interaction and the requirement of the association for Ser/Thr phosphorylation of the enzyme.

Authors:  Z Xie; W T Ho; J H Exton
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 2.  Protein kinase CK2 and its role in cellular proliferation, development and pathology.

Authors:  B Guerra; O G Issinger
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

3.  Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo.

Authors:  A Casamayor; N A Morrice; D R Alessi
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

4.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

5.  Activation of phospholipase D1 by Cdc42 requires the Rho insert region.

Authors:  S J Walker; W J Wu; R A Cerione; H A Brown
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

6.  Phospholipase D1 is phosphorylated and activated by protein kinase C in caveolin-enriched microdomains within the plasma membrane.

Authors:  Y Kim; J M Han; B R Han; K A Lee; J H Kim; B D Lee; I H Jang; P G Suh; S H Ryu
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

7.  Fatty acylation of phospholipase D1 on cysteine residues 240 and 241 determines localization on intracellular membranes.

Authors:  J M Sugars; S Cellek; M Manifava; J Coadwell; N T Ktistakis
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

8.  Casein kinase II phosphorylates the synaptic vesicle protein p65.

Authors:  M K Bennett; K G Miller; R H Scheller
Journal:  J Neurosci       Date:  1993-04       Impact factor: 6.167

9.  Phospholipase D is present on Golgi-enriched membranes and its activation by ADP ribosylation factor is sensitive to brefeldin A.

Authors:  N T Ktistakis; H A Brown; P C Sternweis; M G Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Phosphorylation of the vesicle-tethering protein p115 by a casein kinase II-like enzyme is required for Golgi reassembly from isolated mitotic fragments.

Authors:  A B Dirac-Svejstrup; J Shorter; M G Waters; G Warren
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539

View more
  5 in total

1.  The rice CK2 kinase regulates trafficking of phosphate transporters in response to phosphate levels.

Authors:  Jieyu Chen; Yifeng Wang; Fei Wang; Jian Yang; Mingxing Gao; Changying Li; Yingyao Liu; Yu Liu; Naoki Yamaji; Jian Feng Ma; Javier Paz-Ares; Laurent Nussaume; Shuqun Zhang; Keke Yi; Zhongchang Wu; Ping Wu
Journal:  Plant Cell       Date:  2015-02-27       Impact factor: 11.277

2.  Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins.

Authors:  Caroline Subra; David Grand; Karine Laulagnier; Alexandre Stella; Gérard Lambeau; Michael Paillasse; Philippe De Medina; Bernard Monsarrat; Bertrand Perret; Sandrine Silvente-Poirot; Marc Poirot; Michel Record
Journal:  J Lipid Res       Date:  2010-04-27       Impact factor: 5.922

3.  Phospholipase D2 is localized to the rims of the Golgi apparatus in mammalian cells.

Authors:  Zachary Freyberg; Sylvain Bourgoin; Dennis Shields
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

Review 4.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 5.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.